TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34098002

Group type: EXPERIMENTAL
Intervention: Best-Worst Scaling for food quality attributes
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Focus group discussions
Number of subjects: 264
Study: 34327833

Group type: EXPERIMENTAL
Intervention: Topical monotherapy
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Intensive approach using drugs from three different classes plus 360° laser trabeculoplasty
Number of subjects: 242

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 242
Study: 34021404

Group type: EXPERIMENTAL
Intervention: CAF + CTG
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: CAF + XDM
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 42
Study: 32415720

Group type: EXPERIMENTAL
Intervention: CNTO 7160 (3 mg/kg) in patients with AD
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: CNTO 7160 (3 or 10 mg/kg) in patients with asthma or AD
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: CNTO 7160 (1-10 mg/kg)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: CNTO 7160 (1 mg/kg IV every 2 weeks)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: CNTO 7160
Number of subjects: 68
Study: 36071623

Group type: EXPERIMENTAL
Intervention: Intervention group (n=27) received four one-hour low back pain-related education sessions in addition to eight 45-minute standard physical therapy sessions over 4 weeks.
Number of subjects: 54
Study: 33694311

Group type: EXPERIMENTAL
Intervention: Lisinopril (ACEi)
Number of subjects: 66
Study: 33829819

Group type: EXPERIMENTAL
Intervention: Prolonged Focus on Change (PFC, N = 40)
Number of subjects: 80

Group type: COMPARATOR
Intervention: State‐Of‐The‐Art (SOTA, N = 40)
Number of subjects: 80
Study: 35232389

Group type: EXPERIMENTAL
Intervention: iSupport-Portugal
Number of subjects: 42

Group type: COMPARATOR
Intervention: Education-only e-book (Control)
Number of subjects: 42
Study: 33235115

Group type: EXPERIMENTAL
Intervention: Catgut implantation at acupoints (CIA)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 216
Study: 36049646

Group type: EXPERIMENTAL
Intervention: RLRL therapy (100% power)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Sham device (10% power)
Number of subjects: 112
Study: 34285318

Group type: EXPERIMENTAL
Intervention: Combined NMES with MCE (COMB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham-NMES with MCE (MCE)
Number of subjects: 60

Group type: COMPARATOR
Intervention: NoLBP group
Number of subjects: 60
Study: 32466496

Group type: EXPERIMENTAL
Intervention: Dance fitness group based on Zumba Fitness classes (DF group, n = 25)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Dance fitness + functional strength training group (DFFT group, n = 20)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (n = 20)
Number of subjects: 65
Study: 35281702

Group type: EXPERIMENTAL
Intervention: 12-week web-based self-help program
Number of subjects: 152

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 152
Study: 32420972

Group type: EXPERIMENTAL
Intervention: Lertal® nutraceutical (active group, AG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 0
Study: 35569503

Group type: EXPERIMENTAL
Intervention: EMPOWER
Number of subjects: 86

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 86
Study: 32023185

Group type: EXPERIMENTAL
Intervention: Exercise group (n = 23)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Wait-list group (n = 23)
Number of subjects: 46
Study: 35718656

Group type: EXPERIMENTAL
Intervention: tedizolid phosphate 200 mg once daily for 7 days
Number of subjects: 53

Group type: COMPARATOR
Intervention: linezolid 600 mg twice daily for 10 days
Number of subjects: 53
Study: 33812218

Group type: EXPERIMENTAL
Intervention: Berberine (900mg/day)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 35034050

Group type: EXPERIMENTAL
Intervention: Randomized response technique (RRT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Demographic characteristics (younger, college education, single, employed, Han ethnicity, diagnosed with HIV in the past 6 years, not on antiretroviral therapy)
Number of subjects: 0
Study: 33758387

Group type: EXPERIMENTAL
Intervention: Myo-inositol treatment
Number of subjects: 638

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 638
Study: 33113596

Group type: EXPERIMENTAL
Intervention: Riluzole (100 mg/d for 8 weeks)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 35272400

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) at Neimadian and Zusanli (ST 36), 2 Hz/100 Hz frequency, 1 mA intensity, lasting 30 min.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Tramadol hydrochloride injection, 1 mg/kg intravenously.
Number of subjects: 80
Study: 32518394

Group type: EXPERIMENTAL
Intervention: Brimonidine tartrate 0.15% ophthalmic solution
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (artificial tear instilled in left eye)
Number of subjects: 36
Study: 33724358

Group type: EXPERIMENTAL
Intervention: Environmental factors (relative humidity, temperature, floor covering type, number of occupants)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: House dust mites (D. pteronyssinus and D. farinae)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Mean density of house dust mites
Number of subjects: 64
Study: 32147053

Group type: EXPERIMENTAL
Intervention: Salt water bath (Group B) - 250 grams of powdered mineral salt dissolved in warm water (40-45 °C) for 15 minutes each night for one month.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Warm water bath (Group A) - warm tolerable water (40-45 °C) for 15 minutes each night for one month.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (Group C) - no intervention.
Number of subjects: 60
Study: 35585604

Group type: EXPERIMENTAL
Intervention: Legume-based DASH diet
Number of subjects: 300

Group type: COMPARATOR
Intervention: DASH diet
Number of subjects: 300
Study: 33234158

Group type: EXPERIMENTAL
Intervention: Ivermectin (2 tablets of 6 mg for patients 48-80 kg, 3 tablets for 80-110 kg, 4 tablets for >110 kg) administered at inclusion and 24 hours later.
Number of subjects: 500

Group type: COMPARATOR
Intervention: Placebo (2 tablets of 6 mg for patients 48-80 kg, 3 tablets for 80-110 kg, 4 tablets for >110 kg) administered at inclusion and 24 hours later.
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Ivermectin
Number of subjects: 500

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 500
Study: 35589070

Group type: EXPERIMENTAL
Intervention: Nutrition literacy level assessed using the Nutrition Literacy Assessment Instrument
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Low nutrition literacy
Number of subjects: 112
Study: 32281579

Group type: EXPERIMENTAL
Intervention: 2 g AZD0585
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: 4 g AZD0585
Number of subjects: 383

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: AZD0585
Number of subjects: 383
Study: 35718790

Group type: EXPERIMENTAL
Intervention: Maltodextrin and fructose beverage (800 mL at 10 hours and 400 mL at 2 hours before surgery)
Number of subjects: 231

Group type: COMPARATOR
Intervention: Water (control group)
Number of subjects: 231
Study: 33409924

Group type: EXPERIMENTAL
Intervention: Zinc therapy
Number of subjects: 105

Group type: COMPARATOR
Intervention: No zinc therapy (Control)
Number of subjects: 105
Study: 36374436

Group type: EXPERIMENTAL
Intervention: Remotely delivered EnhanceFitness (tele‐EF) exercise program, 1 hour, 3 days/week for 16 weeks (n=20)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Waitlist control group (n=19)
Number of subjects: 39
Study: 33243300

Group type: EXPERIMENTAL
Intervention: Unguided StudiCare Mindfulness (StudiCare-M)
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: Guidance on Demand (GoD) StudiCare Mindfulness (StudiCare-M)
Number of subjects: 387

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 387
Study: 36118673

Group type: EXPERIMENTAL
Intervention: Dapagliflozin (5 mg daily) plus original oral hypoglycemic agents
Number of subjects: 80

Group type: COMPARATOR
Intervention: Original oral hypoglycemic agents alone (control group)
Number of subjects: 80
Study: 34225743

Group type: EXPERIMENTAL
Intervention: Digital chest drain
Number of subjects: 209

Group type: COMPARATOR
Intervention: Traditional chest drain
Number of subjects: 209
Study: 32590183

Group type: EXPERIMENTAL
Intervention: Conclusions of arguments
Number of subjects: 0

Group type: COMPARATOR
Intervention: Assertions
Number of subjects: 0
Study: 33931815

Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan (sac/val)
Number of subjects: 0

Group type: COMPARATOR
Intervention: enalapril
Number of subjects: 0
Study: 33845654

Group type: EXPERIMENTAL
Intervention: Transmucosal diamorphine
Number of subjects: 28

Group type: COMPARATOR
Intervention: Oral morphine
Number of subjects: 28
Study: 32490924

Group type: EXPERIMENTAL
Intervention: Cervical headgear
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (untreated individuals)
Number of subjects: 45
Study: 35845981

Group type: EXPERIMENTAL
Intervention: External radiation therapy
Number of subjects: 30
Study: 33227589

Group type: EXPERIMENTAL
Intervention: Animated characters
Number of subjects: 92

Group type: COMPARATOR
Intervention: Live-action humans
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Animals
Number of subjects: 92

Group type: COMPARATOR
Intervention: Animated anthropomorphic animals
Number of subjects: 92
Study: 35908254

Group type: EXPERIMENTAL
Intervention: Masupirdine treatment
Number of subjects: 564

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 564
Study: 34981468

Group type: EXPERIMENTAL
Intervention: Curcumin (500 mg/day)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study: 35073129

Group type: EXPERIMENTAL
Intervention: Brief online educational intervention
Number of subjects: 1297

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 1297
Study: 32964379

Group type: EXPERIMENTAL
Intervention: Trans-aortic axial flow devices (Impella)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Extracorporeal centrifugal pumps
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New TCS platforms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Systems of care
Number of subjects: 0
Study: 33597439

Group type: EXPERIMENTAL
Intervention: Maternal vitamin A supplementation (10,000 IU three times per week until delivery, followed by 200,000 IU at delivery and every three months until infants were 12 months old)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Placebo (administered at the same frequency as the vitamin A supplementation)
Number of subjects: 152
Study: 35150610

Group type: EXPERIMENTAL
Intervention: Convalescent plasma (250-300 mL of high anti-SARS-CoV-2 IgG titres methylene blue-treated convalescent plasma)
Number of subjects: 376

Group type: COMPARATOR
Intervention: Placebo (250 mL of sterile 0.9% saline solution)
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Convalescent plasma
Number of subjects: 376

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 376
Study: 33539215

Group type: EXPERIMENTAL
Intervention: Pertuzumab
Number of subjects: 4805

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4805
Study: 32364879

Group type: EXPERIMENTAL
Intervention: Opt-out strategy for patient enrollment in surgical infection research
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized controlled trial comparing surgery with non-operative intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Open access journals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Funding allocation
Number of subjects: 0
Study: 34180500

Group type: EXPERIMENTAL
Intervention: Yoga intervention for 10 weeks
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group with routine exercises
Number of subjects: 61
Study: 32945175

Group type: EXPERIMENTAL
Intervention: FDPP (faith-based diabetes prevention program)
Number of subjects: 221

Group type: COMPARATOR
Intervention: SDPP (standard diabetes prevention program)
Number of subjects: 221
Study: 34289408

Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Montelukast
Number of subjects: 488
Study: 32464566

Group type: EXPERIMENTAL
Intervention: Computer simulation-based, interactive communication education (ComEd) program
Number of subjects: 131

Group type: COMPARATOR
Intervention: Attention control (AC) program
Number of subjects: 131
Study: 36266539

Group type: EXPERIMENTAL
Intervention: Baxdrostat 0.5 mg
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Baxdrostat 1.5 mg
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Baxdrostat 2.5 mg
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Baxdrostat 5.0 mg
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 32557911

Group type: EXPERIMENTAL
Intervention: Sleep group (2-hour nap opportunity)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wake group (passively resting for 2 hours)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 35832302

Group type: EXPERIMENTAL
Intervention: Operating room nursing intervention and nanoceramic prosthesis
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 120
Study: 36429579

Group type: EXPERIMENTAL
Intervention: Moral public health messages
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Immoral public health messages
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Neutral public health messages
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Health benefits framing
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Health risks framing
Number of subjects: 612
Study: 32201109

Group type: EXPERIMENTAL
Intervention: Transdermal buprenorphine (TDB) patch 5 mcg applied at the end of surgery
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional analgesics (combination of paracetamol and tramadol)
Number of subjects: 200
Study: 33749571

Group type: EXPERIMENTAL
Intervention: Thiamine 1.5 mg/kg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Thiamine supplementation
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet with thiamine
Number of subjects: 24
Study: 33472582

Group type: EXPERIMENTAL
Intervention: SGB (Stellate Ganglion Block)
Number of subjects: 102

Group type: COMPARATOR
Intervention: nSGB (no Stellate Ganglion Block)
Number of subjects: 102
Study: 35323965

Group type: EXPERIMENTAL
Intervention: Osimertinib
Number of subjects: 122
Study: 34587700

Group type: EXPERIMENTAL
Intervention: Bovine milk-derived MFGM-enriched formula (MF)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Standard formula (SF)
Number of subjects: 212
Study: 32645079

Group type: EXPERIMENTAL
Intervention: Roller pump (RP group)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Centrifugal pump (CFP group)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Both groups (RP and CFP)
Number of subjects: 80
Study: 35143553

Group type: EXPERIMENTAL
Intervention: Nutrient warning
Number of subjects: 8061

Group type: COMPARATOR
Intervention: GDA
Number of subjects: 8061

Group type: COMPARATOR
Intervention: Nutri-Score
Number of subjects: 8061

Group type: COMPARATOR
Intervention: No label
Number of subjects: 8061
Study: 34507061

Group type: EXPERIMENTAL
Intervention: Woebot‐SUDs (W‐SUDs) for 8 weeks
Number of subjects: 180

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 180
Study: 33669796

Group type: EXPERIMENTAL
Intervention: ME‐WE intervention consisting of seven 2‐h sessions in a group format based on Hayes and Ciarrochi’s psychoeducational model.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist control group.
Number of subjects: 0
Study: 32149954

Group type: EXPERIMENTAL
Intervention: Ingenol Mebutate Gel 0.05%
Number of subjects: 67

Group type: COMPARATOR
Intervention: Podophyllin Solution 25%
Number of subjects: 67
Study: 35114980

Group type: EXPERIMENTAL
Intervention: Ward-based intervention plus treatment as usual
Number of subjects: 34

Group type: COMPARATOR
Intervention: Treatment as usual only
Number of subjects: 34
Study: 33063201

Group type: EXPERIMENTAL
Intervention: Overuse Index (OI)
Number of subjects: 1994636

Group type: EXPERIMENTAL
Intervention: Proportion of primary care physicians (PCPs)
Number of subjects: 1994636

Group type: EXPERIMENTAL
Intervention: Proportion of low-income people
Number of subjects: 1994636
Study: 32553436

Group type: EXPERIMENTAL
Intervention: Cocktail therapy (20 mL of 0.75% ropivacaine, 5 mg of morphine, 0.3 mg of epinephrine, 2 mg of betamethasone, saline solution to a total of 42 mL)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Cocktail therapy
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control (20 mL of 0.75% ropivacaine and saline solution to a total of 42 mL)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control
Number of subjects: 128
Study: 35255913

Group type: EXPERIMENTAL
Intervention: Referral to specialized health facilities
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Referral to lower level facilities
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Provider characteristics related to referrals
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Core-periphery correlation scores (CP) for provider networks
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Core-periphery correlation scores (CP) for facility networks
Number of subjects: 152
Study: 34612707

Group type: EXPERIMENTAL
Intervention: RYGB-S (robotic approach)
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: RYGB-Xi (robotic approach)
Number of subjects: 495

Group type: COMPARATOR
Intervention: Laparoscopic RYGB
Number of subjects: 495
Study: 36063807

Group type: EXPERIMENTAL
Intervention: Nutritional formula
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Nutritional formula (good consumers, intake ≥50% of recommended dose)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Nutritional formula (poor consumers, intake <50% of recommended dose)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study: 34909955

Group type: EXPERIMENTAL
Intervention: Group hope therapy (8 sessions of 90 minutes each using Snyder's method)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no intervention mentioned)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Group hope therapy
Number of subjects: 45
Study: 35651824

Group type: EXPERIMENTAL
Intervention: BTP+TAU
Number of subjects: 34

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 34
Study: 34628735

Group type: EXPERIMENTAL
Intervention: Hand-held moxibustion
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Moxibustion shelf
Number of subjects: 90

Group type: COMPARATOR
Intervention: Imitation moxibustion apparatus
Number of subjects: 90
Study: 34320552

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Sleep Disturbance and Fatigue (CBT‐SF)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Attentionally equivalent health education control
Number of subjects: 30
Study: 33273579

Group type: EXPERIMENTAL
Intervention: Advanced education level
Number of subjects: 11509

Group type: EXPERIMENTAL
Intervention: Intermediate education level
Number of subjects: 11509

Group type: EXPERIMENTAL
Intervention: Education (Mendelian randomization analysis)
Number of subjects: 11509

Group type: EXPERIMENTAL
Intervention: Higher education level
Number of subjects: 11509
Study: 32679601

Group type: EXPERIMENTAL
Intervention: Single-bite technique
Number of subjects: 48

Group type: COMPARATOR
Intervention: Double-bite technique
Number of subjects: 48
Study: 32475914

Group type: EXPERIMENTAL
Intervention: Hypnotic drug use (including benzodiazepine receptor agonists)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Benzodiazepine receptor agonists
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Ramelteon
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Suvorexant
Number of subjects: 111
Study: 36319696

Group type: EXPERIMENTAL
Intervention: Synbiotic (n = 33) comprising mixed‐chain length oligosaccharides and nine microbial strains
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo (n = 31)
Number of subjects: 64
Study: 34580640

Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation program
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard care after CABG
Number of subjects: 50
Study: 33028256

Group type: EXPERIMENTAL
Intervention: Active monitoring
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radical radiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prostatectomy
Number of subjects: 0
Study: 34647795

Group type: EXPERIMENTAL
Intervention: Surfactant (10 mg/mL dipalmitoylphosphatidylcholine; DPPC)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Saline-based liquid aerosols
Number of subjects: 16
Study: 34288546

Group type: EXPERIMENTAL
Intervention: i.v. high-dose furosemide plus HSS
Number of subjects: 141

Group type: COMPARATOR
Intervention: furosemide alone
Number of subjects: 141
Study: 33506455

Group type: EXPERIMENTAL
Intervention: EUS-FNB alone
Number of subjects: 235

Group type: COMPARATOR
Intervention: EUS-FNA+ROSE
Number of subjects: 235
Study: 34016662

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC) during lower-leg immobilisation
Number of subjects: 700

Group type: COMPARATOR
Intervention: Treatment-as-usual (Control)
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC)
Number of subjects: 700
Study: 33326634

Group type: EXPERIMENTAL
Intervention: Fractional micro‐plasma RF
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fractional microneedle RF
Number of subjects: 60
Study: 34785310

Group type: EXPERIMENTAL
Intervention: Anodal tDCS combined with VMT
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (VMT only)
Number of subjects: 30
Study: 33162300

Group type: EXPERIMENTAL
Intervention: Rheumatoid arthritis patients with heart failure (HF)
Number of subjects: 355
Study: 32682554

Group type: EXPERIMENTAL
Intervention: Enhanced auditory display (varying pitch plus tremolo and acoustic brightness)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard auditory display (varying pitch plus alarm)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Enhanced auditory display
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard auditory display
Number of subjects: 20